Paul R. Ingram - Concepedia

Author

Paul R. Ingram

The University of Western Australia ORCID

Also Known As

Amy Crowe, P Ingram, P R Ingram, P. Ingram, P. R. Ingram, P.R. Ingram, P. R. INGRAM, Paul Ingram, Paul R Ingram, Paul R. INGRAM

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

The University of Western Australia Royal Perth Hospital Fiona Stanley Hospital The University of Queensland Pathwest Laboratory Medicine

About

Paul R. Ingram is an author at The University of Western Australia specializing in medicine, microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	19	739
2	Public Health	5	5	98
3	Health Sciences	4	4	167
4	Biochemistry	4	4	138
5	Nursing	1	1	15

Paul R. Ingram

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance Patrick N. A. Harris, Paul Anantharajah Tambyah, David Chien Lye, JAMA	2018	731
Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy Paul R. Ingram, David Chien Lye, Paul Anantharajah Tambyah, Journal of Antimicrobial Chemotherapy	2008	163
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study Andrew Henderson, David L. Paterson, Mark D. Chatfield, Clinical Infectious Diseases	2020	147
Development of Colorimetric Microtiter Plate Assay for Assessment of Antimicrobials against <i>Acanthamoeba</i> James McBride, Paul R. Ingram, Fiona L. Henriquez, Journal of Clinical Microbiology Antimicrobial ChemotherapyBacterial PathogensDrug ResistanceAntimicrobial TherapyInfection Control	2005	125
Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection Paul R. Ingram, Tim Inglis, David Moxon, Intensive Care Medicine PathogenesisImmunologyInfluenza VaccineH1n1 Influenza InfectionFlu Vaccination	2010	100
Point‐prevalence study of inappropriate antibiotic use at a tertiary Australian hospital Paul R. Ingram, J. M. Seet, Charley Budgeon, Internal Medicine Journal	2012	98
Genomic Characteristics of NDM-Producing Enterobacteriaceae Isolates in Australia and Their <i>bla</i> <sub>NDM</sub> Genetic Contexts Alexander M. Wailan, David L. Paterson, Karina Kennedy, Antimicrobial Agents and Chemotherapy	2015	74
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial Patrick N. A. Harris, Anton Y. Peleg, Jonathan R. Iredell, Trials	2015	73
Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy Paul R. Ingram, David Chien Lye, Dale Fisher, International Journal of Antimicrobial Agents Antimicrobial StewardshipAntibioticsMedicineAntimicrobial ResistanceAntimicrobial Chemotherapy	2009	71
Continuous Infusions of Meropenem in Ambulatory Care: Clinical Efficacy, Safety and Stability Laurens Manning, Cameron Wright, Paul R. Ingram, PLoS ONE	2014	67

Page 1